NCT01553903View on ClinicalTrials.gov

Feasibility Study for the Determination of Oxysterols in Patients With Breast Cancer Receiving Hormonal Therapy With Tamoxifen or Not

PHASE4CompletedINTERVENTIONAL
Enrollment

29

Participants

Timeline

Start Date

December 31, 2011

Primary Completion Date

May 31, 2013

Study Completion Date

May 31, 2013

Conditions
Breast Cancer
Interventions
DRUG

Tamoxifen,

Tamoxifen 20 mg/day during 5 years,

DRUG

Exemestane

Exemestane 25mg/day during 5 years

DRUG

Anastrozole

Anastrozole 1 mg/day during 5 years,

DRUG

Letrozole

Letrozole 2.5 mg/day during 5 years,

Trial Locations (1)

31052

Institut Claudius REGAUD, Toulouse

All Listed Sponsors
lead

Institut Claudius Regaud

OTHER

NCT01553903 - Feasibility Study for the Determination of Oxysterols in Patients With Breast Cancer Receiving Hormonal Therapy With Tamoxifen or Not | Biotech Hunter | Biotech Hunter